Please enable JS

FDA public Meeting Statement on Abuse Deterrent Opioid Formulations

FILTER BY TYPE

Most Recent

Categories

ARCHIVES

FDA public Meeting Statement on Abuse Deterrent Opioid Formulations

Oct 30// Advocate Testimony Opioids

FDA public Meeting Statement on Abuse Deterrent Opioid Formulations 10-30-14

READ MORE

Idaho Board of Pharmacy Proposed Rule Testimony

Oct 22// Advocate Testimony

GHLF Idaho Board of Pharmacy Proposed Rule Testimony 10-22-14

READ MORE

Idaho Board of Pharmacy Testimony

Aug 08// Advocate Testimony

GHLF Idaho Board of Pharmacy Testimony 8-6-14

READ MORE

Indiana Health Finance Commission Biosimilars Testimony

Aug 08// Advocate Testimony Biosimilars

GHLF Indiana Health Finance Commission Biosimilars Testimony

READ MORE

Pennsylvania House Biosimilars Testimony

Aug 08// Advocate Testimony Biosimilars

GHLF Pennsylvania House Biosimilars Testimony

READ MORE